1. Home
  2. CDNA vs QRTEB Comparison

CDNA vs QRTEB Comparison

Compare CDNA & QRTEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • QRTEB
  • Stock Information
  • Founded
  • CDNA 1998
  • QRTEB 1991
  • Country
  • CDNA United States
  • QRTEB United States
  • Employees
  • CDNA N/A
  • QRTEB N/A
  • Industry
  • CDNA Medical Specialities
  • QRTEB Catalog/Specialty Distribution
  • Sector
  • CDNA Health Care
  • QRTEB Consumer Discretionary
  • Exchange
  • CDNA Nasdaq
  • QRTEB Nasdaq
  • Market Cap
  • CDNA 1.1B
  • QRTEB 1.1B
  • IPO Year
  • CDNA 2014
  • QRTEB N/A
  • Fundamental
  • Price
  • CDNA $23.34
  • QRTEB $2.87
  • Analyst Decision
  • CDNA Buy
  • QRTEB
  • Analyst Count
  • CDNA 8
  • QRTEB 0
  • Target Price
  • CDNA $27.17
  • QRTEB N/A
  • AVG Volume (30 Days)
  • CDNA 642.2K
  • QRTEB 8.9K
  • Earning Date
  • CDNA 02-26-2025
  • QRTEB 02-26-2025
  • Dividend Yield
  • CDNA N/A
  • QRTEB N/A
  • EPS Growth
  • CDNA N/A
  • QRTEB N/A
  • EPS
  • CDNA N/A
  • QRTEB N/A
  • Revenue
  • CDNA $312,775,000.00
  • QRTEB $10,236,000,000.00
  • Revenue This Year
  • CDNA $19.85
  • QRTEB N/A
  • Revenue Next Year
  • CDNA $11.34
  • QRTEB N/A
  • P/E Ratio
  • CDNA N/A
  • QRTEB N/A
  • Revenue Growth
  • CDNA 5.26
  • QRTEB N/A
  • 52 Week Low
  • CDNA $7.42
  • QRTEB $2.87
  • 52 Week High
  • CDNA $34.84
  • QRTEB $2.87
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 56.42
  • QRTEB 44.38
  • Support Level
  • CDNA $20.35
  • QRTEB $2.54
  • Resistance Level
  • CDNA $21.68
  • QRTEB $3.29
  • Average True Range (ATR)
  • CDNA 1.10
  • QRTEB 0.38
  • MACD
  • CDNA 0.19
  • QRTEB -0.01
  • Stochastic Oscillator
  • CDNA 99.09
  • QRTEB 34.37

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

About QRTEB Qurate Retail Inc. Series B

Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, using their televised shopping programs and via the Internet through their websites and mobile applications; QVC International segment markets and sells a wide variety of consumer products in several foreign countries, using its televised shopping programs and via the Internet through its international websites and mobile applications; and Zulily markets and sells a wide variety of consumer products in the United States and several foreign countries. Geographically, the company operates in U.S, which generates key revenue, Japan, Germany and other regions.

Share on Social Networks: